Title : BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression.

Pub. Date : 2022 May

PMID : 35184257






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression. naringenin BCL2 like 1 Homo sapiens
2 BCL2L1 was identified as the candidate target of naringenin against OC. naringenin BCL2 like 1 Homo sapiens
3 Naringenin decreased BCL2L1 expression and inactivated the PI3K/Akt pathway in OC cells. naringenin BCL2 like 1 Homo sapiens
4 Naringenin inhibited cell proliferation and increased the apoptotic rate in OC cells, while these effects were partially abolished by BCL2L1 overexpression and treatment with 740Y-P, a PI3K activator. naringenin BCL2 like 1 Homo sapiens
5 In conclusion, naringenin exerted an anti-tumor effect on OC progression via inactivation of the PI3K/Akt/BCL2L1 pathway. naringenin BCL2 like 1 Homo sapiens